Neurofeedback Mechanism of Action and Brain Adaptation Ability:

Professor Pavlov received the Nobel Prize in 1904 after applying operant conditioning, a method used in neurofeedback, to his dog.

 

Psychiatrist Professor Dr. Eric Kandel from Columbia Medical School in America won the Nobel Prize in 2000 for demonstrating that classical conditioning and operant conditioning (including RNA/DNA mechanisms) are universal synaptic mechanisms in all animals, including humans. He stated that sensitization and habituation are based on scientific findings, but are generally not effective or long-lasting. They do not have the same plasticity mechanism as operant and classical conditioning.

Pediatric neurologist Professor Dr. Frank Duffy is a clinical neurophysiologist at the Children's Hospital affiliated with Harvard Medical School and directs the developmental neurophysiology research laboratories, and is also one of the neurology editors of the Clinical EEG journal. In January 2000, in Vol: 31 No: 1 of the journal, it was stated: “The literature shows no negative studies regarding EEG Biofeedback and recommends that EEG biofeedback should have a major therapeutic role in many areas. My personal opinion is that if any drug were so effective in such a wide range of areas, it would be accepted or widely used worldwide.”

On May 26, 2011, Science published a study by Robert Schafer of Stanford University School of Medicine scientifically explaining why Neurofeedback therapy works (Selective Attention from Voluntary Control of Neurons in Prefrontal Cortex).

 

Professor Dr. Ruth A. Lanius, a psychiatrist at the University of Western Ontario, and scientists at the University of Geneva, in their article explaining why Neurofeedback therapy works, also mention that Neurofeedback therapy has no side effects.

Psychiatrist Dr. In an article published in 1995, Andrew Abarbanel discussed the neurophysiological similarities between electrophysiological and neurophysiological processes underlying the benefits of Neurofeedback (NFB) training in attention deficit hyperactivity disorder (ADHD), depression, obsessive-compulsive disorder (OCD), and schizophrenia. He explained the observed effects of Neurofeedback on depression and OCD and discussed the possibility of adapting Neurofeedback to the treatment of schizophrenia. (Abarbanel studied Physics and Mathematics at Stanford University, received a PhD in Physics, and then received medical training at the same university. He completed his residency in 1982 at Harvard's Mt. Auburn and McLean hospitals.)

Neurofeedback Treatment for the Brain:

Professor Dr. Andrew Abarbanel, Pediatric Neurology Specialist Frank Duffy, head of Clinical Neuroimaging Research and Neuroimaging at Boston Children's Hospital, Harvard Medical School, conducted an independent review of the literature on neurofeedback (2000). He summarized his findings as follows:

"The literature shows no negative studies and suggests that EEG biofeedback therapy should play a significant therapeutic role in many challenging areas. In my opinion, if any drug had such a wide range of effects, it would be universally accepted and widely used."